19.03.2018 21:15:00

Diplomat to Present at 2018 Needham & Company Healthcare Conference

FLINT, Mich., March 19, 2018 /PRNewswire/ -- Diplomat Pharmacy Inc. (NYSE: DPLO) will participate in Needham & Company's 17th annual healthcare conference in New York City.

Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.)

Interim CEO Jeff Park and Chief Financial Officer Atul Kavthekar are scheduled to present at 11:30 a.m. ET Wednesday, March 28.

Live audio-only webcasts of the presentation and related materials will be available on the investor relations section of Diplomat's website at ir.diplomat.is. The webcast and presentation materials will be online for 90 days.

About Diplomat
Diplomat (NYSE: DPLO) is the nation's largest independent provider of specialty pharmacy services—helping patients and providers in all 50 states. The company offers medication management programs for people with complex chronic diseases and delivers unique solutions for manufacturers, hospitals, payers, providers, and more. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients and the rest falls into place." Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information, visit diplomat.is.

INVESTOR CONTACT:
Atul Kavthekar, Chief Financial Officer
810.768.9380 | akavthekar@diplomat.is

MEDIA CONTACT:
Jenny Cretu, Senior Vice President,
Pharma Services and Marketing
810.768.9370 | jcretu@diplomat.is

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/diplomat-to-present-at-2018-needham--company-healthcare-conference-300616023.html

SOURCE Diplomat Pharmacy Inc.

Nachrichten zu Diplomat Pharmacy Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Diplomat Pharmacy Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!